Cytek Biosciences Files 8-K on Financials
Ticker: CTKB · Form: 8-K · Filed: Jan 15, 2025 · CIK: 1831915
| Field | Detail |
|---|---|
| Company | Cytek Biosciences, Inc. (CTKB) |
| Form Type | 8-K |
| Filed Date | Jan 15, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: CYTK
TL;DR
CYTK filed an 8-K on Jan 15, 2025, detailing financial results. Check it out.
AI Summary
Cytek Biosciences, Inc. filed an 8-K on January 15, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the period ending January 15, 2025. The company is incorporated in Delaware and headquartered in Fremont, California.
Why It Matters
This 8-K filing provides an update on Cytek Biosciences' financial performance and condition, which is crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting financial information and does not indicate any unusual or significant risks.
Key Players & Entities
- Cytek Biosciences, Inc. (company) — Registrant
- January 15, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Fremont, California (location) — Principal Executive Offices
- 001-40632 (identifier) — SEC File Number
FAQ
What specific financial information is being reported in this 8-K?
The 8-K states it is reporting on 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K filed?
This 8-K was filed on January 15, 2025.
What is the principal business address of Cytek Biosciences, Inc.?
The principal executive offices are located at 47215 Lakeview Boulevard, Fremont, California, 94538.
What is the SEC file number for Cytek Biosciences, Inc.?
The SEC file number is 001-40632.
In which state was Cytek Biosciences, Inc. incorporated?
Cytek Biosciences, Inc. was incorporated in Delaware.
Filing Stats: 496 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-01-15 08:30:46
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share CTKB Nasdaq Global Select
Filing Documents
- d914343d8k.htm (8-K) — 25KB
- d914343dex991.htm (EX-99.1) — 13KB
- 0001193125-25-006599.txt ( ) — 159KB
- ctkb-20250115.xsd (EX-101.SCH) — 3KB
- ctkb-20250115_lab.xml (EX-101.LAB) — 17KB
- ctkb-20250115_pre.xml (EX-101.PRE) — 11KB
- d914343d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description of Exhibit 99.1 Press release dated January 15, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cytek Biosciences, Inc. Date: January 15, 2025 By: /s/ Wenbin Jiang Wenbin Jiang, Ph.D. President and Chief Executive Officer